Product Information
RUFINAMIDE 400 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.3904 per EA under NDC 68462071408. Its NADAC has been published 245 times since Oct 20, 2021.
Strength
400 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462071408
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RUFINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205075On Market Since
5/16/2016
Price Statistics
The NADAC for RUFINAMIDE 400 MG TABLET has been published 245 times since Oct 20, 2021, and over the history we have for it it has declined 76.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3904 per EA |
|---|---|
| All-time high | $5.9562 (Jan 12, 2022) |
| All-time low | $1.3608 (May 20, 2026) |
| 52-week high | $1.7050 |
| 52-week low | $1.3608 |
| Median price | $3.6425 |
| Average price | $3.4351 |
| Largest weekly change | -38.3% (May 22, 2024) |
| Weeks tracked | 245 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RUFINAMIDE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 400 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.3904 per EA (NDC 68462071408), effective Jun 24, 2026.
How has the price of RUFINAMIDE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for RUFINAMIDE 400 MG TABLET has declined 76.7%. It has been tracked across 245 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for RUFINAMIDE 400 MG TABLET?
Since Oct 20, 2021, the NADAC for RUFINAMIDE 400 MG TABLET has ranged from a low of $1.3608 (May 20, 2026) to a high of $5.9562 (Jan 12, 2022), with a median of $3.6425 per EA.
Are there cheaper alternatives to RUFINAMIDE 400 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as RUFINAMIDE 400 MG TABLET, but none are currently priced below it.
Who manufactures RUFINAMIDE 400 MG TABLET?
RUFINAMIDE 400 MG TABLET (NDC 68462071408) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification